Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
716.00    7.00 (0.99%)
Bid:
700.00
Ask:
721.00
Spread: 21.00 (3.00%)
Market Cap: £695.39m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Director/PDMR Shareholding

29 Mar 2022 16:29

RNS Number : 4487G
discoverIE Group plc
29 March 2022
Β 

29 March 2022

Β 

discoverIE Group plc

Β 

Director/PDMR Shareholding

Exercise of Share Options

Β 

discoverIE Group plc (LSE:DSCV, "discoverIE" or the "Company"), a leading international designer and manufacturer of customised electronics to industry, has been notified of the following transactions by PDMRs of the Company.

Β 

On 28 March 2022 and 25 March 2022, respectively, Nick Jefferies, Group Chief Executive, and Simon Gibbins, Group Finance Director, exercised 230,070 and 101,300 options over ordinary shares of five pence each of the Company ("Ordinary Shares"), which vested pursuant to an award granted on 31 March 2016 under the Company's 2008 Long Term Incentive Plan.

Β 

In order to satisfy the personal tax liabilities arising on exercise, Mr Jefferies and Mr Gibbins sold 108,568 Ordinary Shares each at a price of 775.00 pence, and 47,803 Ordinary Shares each at a price of 807.50 pence, respectively.

Β 

The balance of the Ordinary Shares held by Mr Jefferies, being 121,502 Ordinary Shares, were immediately transferred to his wife, Susan Jefferies, for nil consideration. Mr Gibbins continues to hold the balance of his exercised award, being 53,497 Ordinary Shares.

Β 

Following the transactions outlined above, Mr Jefferies is interested in a total of 1,241,830 Ordinary Shares representing approximately 1.30 per cent. of the Company's share capital and Mr Gibbins is interested in 388,264 Ordinary Shares representing approximately 0.41 per cent. of the Company's share capital.

Β 

Enquiries:

Β 

discoverIE Group plc 01483 544 500

Β 

Greg Davidson Group General Counsel & Company Secretary

Lili Huang Head of Investor Relations

Β 

Buchanan 020 7466 5000Β 

Chris Lane, Toto Berger, Jack Devoy

discoverIE@buchanan.uk.com

Β 

Notes to Editors:

Β 

About discoverIE Group plc

Β 

discoverIE Group plc is an international group of businesses that designs and manufactures innovative components for electronic applications.

Β 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

Β 

With a focus on key markets driven by structural growth and increasing electronic content, namely renewable energy, medical, transportation and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions. The Group has an ongoing commitment to reducing the impact of its operations on the environment, while its key markets are aligned with a sustainable future.

Β 

The Group's continuing operations employs c.4,500 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

Β 

The Group is listed on the Main Market of the London Stock Exchange and is a member of the FTSE250, classified within the Electrical Components and Equipment subsector.

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nicholas Jefferies

2

Reason for the notification

a)

Position / status

Group Chief Executive

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares in discoverIE Group plc

Β 

Β 

GB0000055888

b)

Nature of the transaction

Β 

1. Exercise of options

Β 

2. Sale of shares

Β 

3. Transfer to a PCA

Β 

c)

Price(s) and volume(s)

Β 

Price

Volume

1. Nil

1. 230,070

2. 775.00 pence

2. 108,568

3. Nil

3. 121,502

Β 

Β 

d)

Aggregated information

Β 

As above

Β 

e)

Date of the transaction

28 March 2022

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Simon Gibbins

2

Reason for the notification

a)

Position / status

Group Finance Director

b)

Initial notification / amendment

Initial notification

3

Details of issuer

a)

Name

discoverIE Group plc

b)

LEI

213800BMDLQU1VEEAN68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares in discoverIE Group plc

Β 

Β 

GB0000055888

b)

Nature of the transaction

Β 

1. Exercise of options

Β 

2. Sale of shares

Β 

Β 

c)

Price(s) and volume(s)

Β 

Price

Volume

1. Nil

1. 101,300

2. 807.50 pence

2. 47,803

Β 

Β 

d)

Aggregated information

Β 

As above

Β 

e)

Date of the transaction

25 March 2022

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHZZGZFKLKGZZM
Date   Source Headline
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings
1st Sep 202210:17 amRNSNotification of Major Holdings
26th Aug 20222:27 pmRNSNotification of Major Holdings
22nd Aug 202210:21 amRNSNotification of Major Holdings
29th Jul 20224:23 pmRNSNotification of Major Holdings
28th Jul 20223:00 pmRNSResults of Annual General Meeting
28th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSAcquisition of the CDT group
27th Jun 20223:44 pmRNSDirector / PDMR Shareholding
24th Jun 20221:00 pmRNSAnnual Report and Notice of AGM
24th Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20229:58 amRNSDirector LTIP Award
15th Jun 20228:03 amRNSNotification of Major Holdings
14th Jun 20227:00 amRNSPreliminary results
6th Jun 20227:00 amRNSNotice of Full Year Results
19th May 20222:38 pmRNSNotification of Major Holdings
11th May 20227:00 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202210:57 amRNSTR-1: Notification of Major Holdings
14th Apr 20227:00 amRNSFull Year Trading Update
7th Apr 20227:00 amRNSdiscoverIE Awarded “A” Rating by MSCI ESG
29th Mar 20224:29 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector Declaration
10th Mar 20223:02 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSHolding(s) in Company
4th Mar 20227:00 amRNSCompletion of Distribution Businesses Disposals
25th Feb 20229:50 amRNSDirector/PDMR Shareholding
9th Feb 20227:00 amRNSTrading Update
9th Feb 20227:00 amRNSChange to Operating Segments
10th Dec 20213:49 pmRNSDirector/PDMR Shareholding
8th Dec 20218:50 amRNSDirector/PDMR Shareholding
6th Dec 20218:30 amRNSIssue of Equity & Total Voting Rights
30th Nov 20217:00 amRNSInterim Results
22nd Nov 20214:05 pmRNSHolding(s) in Company
11th Nov 202112:49 pmRNSNotice of Half Year Results
9th Nov 20217:00 amRNSSale of Acal BFi Distribution Business
4th Nov 20217:00 amRNSAppointment of Non-Executive Director
14th Oct 20217:00 amRNSFirst Half Trading Update
4th Oct 20217:00 amRNSSale of Vertec SA
9th Sep 202110:44 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSResults of Placing
2nd Sep 20215:40 pmRNSAcquisitions & Proposed Placing
5th Aug 20215:30 pmRNSAggreko
30th Jul 20212:06 pmRNSDirector LTIP Award
29th Jul 20214:09 pmRNSResults of Annual General Meeting
29th Jul 20217:00 amRNSTrading Update
28th Jun 202110:09 amRNSHolding(s) in Company
25th Jun 20215:24 pmRNSDirector / PDMR Shareholding
16th Jun 202110:00 amRNSAnnual Report and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.